已收盘 11-13 16:00:00 美东时间
+0.500
+0.77%
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $80 to $85.
11-13 23:52
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
Ovintiv shares are trading lower after the company reported worse-than-expected Q3 adjusted EPS results.
11-05 00:19
Evercore ISI Group analyst Stephen Richardson maintains Ovintiv (NYSE:OVV) with a Outperform and raises the price target from $70 to $77.
11-04 21:31
华盛资讯11月4日讯,Ovintiv公布2026财年Q3业绩,公司Q3营收26.02亿美元,同比增长25.9%,归母净利润5.49亿美元,同比增长270.9%。
11-04 06:16
Ovintiv (TSX:OVV) reported quarterly earnings of $1.95 per share which missed the analyst consensus estimate of $1.99 by 2.01 percent. This is a 89.32 percent increase over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $2.602 billion which beat t...
11-04 06:13
今日重点评级关注:富瑞:维持ArriVent BioPharma"买入"评级,目标价从18美元升至30美元;古根海姆:维持第一太阳能"买入"评级,目标价从282美元升至299美元
10-28 12:30
Goldman Sachs analyst Neil Mehta maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $65 to $72.
10-28 00:56
1、北大医药控股股东西南合成100%股权拟易主,实控人将变更为邦尔骨科系程栋 10月26日,北大医药公告,公司披露详式权益变动报告书及北京博星证券财务顾问核查意...
10-27 14:45